TY - JOUR
T1 - Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance Heralds an Adverse Prognosis in Nonischemic Cardiomyopathy
AU - Wu, Katherine C.
AU - Weiss, Robert G.
AU - Thiemann, David R.
AU - Kitagawa, Kakuya
AU - Schmidt, André
AU - Dalal, Darshan
AU - Lai, Shenghan
AU - Bluemke, David A.
AU - Gerstenblith, Gary
AU - Marbán, Eduardo
AU - Tomaselli, Gordon F.
AU - Lima, João A.C.
N1 - Funding Information:
Supported by the Donald W. Reynolds Cardiovascular Research Center at Johns Hopkins University and the National Heart, Lung, and Blood Institute, National Institutes of Health (K23 HL04444 to Dr. Wu). Drs. Wu and Lima receive research grant support from GE Healthcare Technologies.
PY - 2008/6/24
Y1 - 2008/6/24
N2 - Objectives: We examined whether the presence and extent of late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) predict adverse outcomes in nonischemic cardiomyopathy (NICM) patients. Background: Morbidity and mortality is high in NICM patients. However, the clinical course of an individual patient is unpredictable and current risk stratification approaches are limited. Cardiovascular magnetic resonance detects myocardial fibrosis, which appears as LGE after contrast administration and may convey prognostic importance. Methods: In a prospective cohort study, 65 NICM patients with left ventricular (LV) ejection fraction ≤35% underwent CMR before placement of an implantable cardioverter-defibrillator (ICD) for primary prevention of sudden cardiac death. The CMR images were analyzed for the presence and extent of LGE and for LV function, volumes, and mass. Patients were followed for an index composite end point of 3 cardiac events: hospitalization for heart failure, appropriate ICD firing, and cardiac death. Results: A total of 42% (n = 27) of patients had CMR LGE, averaging 10 ± 13% of LV mass. During a 17-month median follow-up, 44% (n = 12) of patients with LGE had an index composite outcome event versus only 8% (n = 3) of those without LGE (p < 0.001 for Kaplan-Meier survival curves). After adjustment for LV volume index and functional class, patients with LGE had an 8-fold higher risk of experiencing the primary outcome (hazard ratio 8.2, 95% confidence interval 2.2 to 30.9; p = 0.002). Conclusions: A CMR LGE in NICM patients strongly predicts adverse cardiac outcomes. The CMR LGE may represent the end-organ consequences of sustained adrenergic activation and adverse LV remodeling, and its identification may significantly improve risk stratification strategies in this high risk population. (Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk; NCT00181233).
AB - Objectives: We examined whether the presence and extent of late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) predict adverse outcomes in nonischemic cardiomyopathy (NICM) patients. Background: Morbidity and mortality is high in NICM patients. However, the clinical course of an individual patient is unpredictable and current risk stratification approaches are limited. Cardiovascular magnetic resonance detects myocardial fibrosis, which appears as LGE after contrast administration and may convey prognostic importance. Methods: In a prospective cohort study, 65 NICM patients with left ventricular (LV) ejection fraction ≤35% underwent CMR before placement of an implantable cardioverter-defibrillator (ICD) for primary prevention of sudden cardiac death. The CMR images were analyzed for the presence and extent of LGE and for LV function, volumes, and mass. Patients were followed for an index composite end point of 3 cardiac events: hospitalization for heart failure, appropriate ICD firing, and cardiac death. Results: A total of 42% (n = 27) of patients had CMR LGE, averaging 10 ± 13% of LV mass. During a 17-month median follow-up, 44% (n = 12) of patients with LGE had an index composite outcome event versus only 8% (n = 3) of those without LGE (p < 0.001 for Kaplan-Meier survival curves). After adjustment for LV volume index and functional class, patients with LGE had an 8-fold higher risk of experiencing the primary outcome (hazard ratio 8.2, 95% confidence interval 2.2 to 30.9; p = 0.002). Conclusions: A CMR LGE in NICM patients strongly predicts adverse cardiac outcomes. The CMR LGE may represent the end-organ consequences of sustained adrenergic activation and adverse LV remodeling, and its identification may significantly improve risk stratification strategies in this high risk population. (Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk; NCT00181233).
UR - http://www.scopus.com/inward/record.url?scp=45149098840&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=45149098840&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2008.03.018
DO - 10.1016/j.jacc.2008.03.018
M3 - Article
C2 - 18565399
AN - SCOPUS:45149098840
SN - 0735-1097
VL - 51
SP - 2414
EP - 2421
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 25
ER -